Syncona has been granted a patent for an apparatus designed to deliver therapeutic agents to the eye. The device includes a flexible cannula with an atraumatic distal end for safe insertion between the choroid and sclera, along with a needle that can be advanced to deliver treatment near the area of geographic atrophy. GlobalData’s report on Syncona gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Syncona, was a key innovation area identified from patents. Syncona's grant share as of May 2024 was 24%. Grant share is based on the ratio of number of grants to total number of patents.
Apparatus for delivering therapeutic agent to eye through cannula
A recently granted patent (Publication Number: US11998482B2) discloses an innovative apparatus designed for ophthalmic procedures. The apparatus comprises a body, a flexible cannula with an atraumatic distal end for separating the choroid and sclera of a patient's eye, and a needle with a sharp distal tip that can translate within the cannula. The needle includes a pre-bent portion that is resiliently biased at a predetermined angle relative to the longitudinal axis, allowing for precise manipulation during procedures.
Furthermore, the apparatus features a cannula with a non-circular cross-sectional profile, including flat and rounded sides, enhancing stability and control during use. The needle's design ensures it follows a straight path within the cannula but can advance at the predetermined angle when outside the cannula. With the needle's unique characteristics and the cannula's specialized design, this apparatus offers improved functionality and precision for ophthalmic interventions, potentially enhancing patient outcomes and procedural efficiency.
To know more about GlobalData’s detailed insights on Syncona, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
